drugset / Trial / NCT07700719
SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study
Phase 2
Not yet recruiting
17 enrolled
Peking University Cancer Hospital & Institute
Beijing GoBroad Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of SHR-A1904 in the advanced colorectal cancer after failure of standard therapy
Timeline
- Start
- 2026-07-28
- Primary completion
- 2027-11-28
- Completion
- 2028-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-A1904 | Unknown | — | — |